Join our community of smart investors

Consort bounces on drug approval

The medical device manufacturer has received some good news from US regulators
Consort bounces on drug approval

Consort Medical's (CSRT) shares bounced back on news that US regulator, the Food and Drug Administration (FDA), has approved Wixela Hub – a generic copy of GlaxoSmithKline’s (GSK) respiratory drug Advair – made by US-listed pharma group Mylan (US:MYL).

IC TIP: Hold at 940p

To continue reading...
Join our Community of Smart Investors
  • Independent full-length company analysis
  • Actionable investment ideas and recommendations
  • Expert investment tools and data
  • Stock screens from Algy Hall
Have an account? Sign in